Antifungal activity of tamoxifen: in vitro and in vivo activities and mechanistic characterization
about
Antifungal drug discovery: something old and something newAntifungal application of nonantifungal drugsThe triphenylethylenes, a novel class of antifungals.In vitro and in vivo effects of tamoxifen against larval stage Echinococcus granulosusAntifungal drug discovery: the process and outcomes.Structural determination of NSC 670224, synthesis of analogues and biological evaluation.Adenylate kinase release as a high-throughput-screening-compatible reporter of bacterial lysis for identification of antibacterial agents.A repurposing approach identifies off-patent drugs with fungicidal cryptococcal activity, a common structural chemotype, and pharmacological properties relevant to the treatment of cryptococcosisOral administration of the broad-spectrum antibiofilm compound toremifene inhibits Candida albicans and Staphylococcus aureus biofilm formation in vivo.Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms.Estrogen receptor antagonists are anti-cryptococcal agents that directly bind EF hand proteins and synergize with fluconazole in vivo.Structure-activity relationships for the antifungal activity of selective estrogen receptor antagonists related to tamoxifenAntifungal adjuvants: Preserving and extending the antifungal arsenalStrategies in the discovery of novel antifungal scaffolds.The antifungal pipeline: a reality check.Effect of the amino chain length and the transformation into citric acid salts of aryl-diphenyl-butenes and ferrocenyl-diphenyl-butenes bearing two dimethylaminoalkyl chains on their antimicrobial activities.Anti-Candida, anti-enzyme activity and cytotoxicity of 3,5-diaryl-4,5-dihydro-1H-pyrazole-1-carboximidamides.Repurposing an inhibitor of ribosomal biogenesis with broad anti-fungal activity.Functional insights into the Magnaporthe oryzae class II myosin.New Horizons in Antifungal Therapy.Antimicrobial and Antibiofilm Activity of Synergistic Combinations of a Commercially Available Small Compound Library With Colistin Against
P2860
Q28483546-B8E71AFD-D14C-4910-A9D0-DCDE8D6470E5Q30433553-DFA40CD8-5ABE-4DE0-BA45-BEC565D5CC11Q33569534-072EFF13-219C-4F23-8064-D26913B645F2Q34057335-BC3EC15D-2721-482A-9C4B-BA6BB6C25917Q34086897-83925416-53DD-4C0E-B32E-BE824C546A91Q34179561-669F18D7-849B-44C1-915E-D0CE70D35A7BQ34425938-2B2F7680-08B9-4111-B1AE-EEC5EBC0F047Q34513852-456A08C7-14B3-440D-8E42-7DDCCEB7ABD7Q34597915-50D0ECBC-D7C7-49D9-9FEA-586DD3692C77Q35055832-93C98E62-F9BA-41F6-B2B2-D2CB344D15F5Q35092521-F64C7054-E061-4D21-9E68-DDC8B5396689Q35643319-04CBD6A4-7070-43A9-B9A4-9BE7BEB13D22Q37705308-3ABD929B-9AC8-4ECC-BCCF-727713CB141FQ38837363-8F4A4026-5CFC-41EA-A43F-C30EAD861E8EQ39299949-C9626F60-F88F-42B4-926F-7CC2C96434F0Q41829975-C6AB695D-39DF-455E-BE73-4BFEB246F4C4Q45305710-951BADF5-E218-4EBB-BACE-98F029515EA4Q46247342-4B3B51C8-7D3F-4356-8959-9CA9E0D99DA5Q46645915-246BEA7B-017B-4F68-8DBA-C95E8BDB09BDQ48149179-359B75F8-19E0-4FDD-BDD2-682ED456D623Q58556379-6AE55713-D1DA-489A-AD19-59E3C9A2E558
P2860
Antifungal activity of tamoxifen: in vitro and in vivo activities and mechanistic characterization
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antifungal activity of tamoxif ...... d mechanistic characterization
@en
Antifungal activity of tamoxif ...... mechanistic characterization.
@nl
type
label
Antifungal activity of tamoxif ...... d mechanistic characterization
@en
Antifungal activity of tamoxif ...... mechanistic characterization.
@nl
prefLabel
Antifungal activity of tamoxif ...... d mechanistic characterization
@en
Antifungal activity of tamoxif ...... mechanistic characterization.
@nl
P2093
P2860
P356
P1476
Antifungal activity of tamoxif ...... d mechanistic characterization
@en
P2093
Bradley Buchheit
Kristy Dolan
Louis Didone
Sara Montgomery
P2860
P304
P356
10.1128/AAC.01564-08
P407
P577
2009-06-01T00:00:00Z